Fudan University: all 1,308 studies

Page 8 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.

• Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing TechnologyCompletedNCT06366581
• Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in ChinaCompletedNCT06355440Not applicable
• Inosine Reverse Chemo Resistance in Triple Negative Breast CancerCompletedNCT06355024Phase 2
• Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast CancerCompletedNCT06344793
• Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast CancerActive, not recruitingNCT06344780
• Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary TumorCompletedNCT06344767
• Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal AdenocarcinomaCompletedNCT06344299
• NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC RegimensCompletedNCT06331520Phase 3
• First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC PatientsActive, not recruitingNCT06313970Phase 2
• Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer SurgeryCompletedNCT06263205Not applicable
• Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal CancerWithdrawnNCT06221423
• Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world StudyCompletedNCT06202417
• Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder CancerActive, not recruitingNCT06187506Phase 2
• Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)CompletedNCT06170216
• A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung CancerCompletedNCT06161935
• Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based TherapyCompletedNCT06161922
• Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant ReconstructionCompletedNCT06143020Not applicable
• IASLC Grading System as a Predictor for EGFR-TKI TherapyCompletedNCT06131645
• A Retrospective Analysis of Incisional Hernia Repair's Postoperative RecurrenceCompletedNCT06102551
• Acute Health Effects of Low Temperature ExposureActive, not recruitingNCT06076629Not applicable
• Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal CancerCompletedNCT06040021
• A Home Telemonitoring System for Wearable Fetal-ECG and EHG Acquisition During PregnancyCompletedNCT06031142
• Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver MetastasesCompletedNCT06027775
• Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or ReconstructionCompletedNCT06024343Not applicable
• Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver MetastasesCompletedNCT06023173
• SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKIActive, not recruitingNCT06020066Phase 2
• Vitamin C to Chemotherapy Related Anemia in Pancreatic CancerActive, not recruitingNCT06018883Phase 3
• Pulmonary Ventilation Function Between Patients With Primary and Recurrent Incisional Hernia: a Cross-sectional StudyCompletedNCT05991024
• PET-CT Predicting Lymph Nodes MetastasisActive, not recruitingNCT05970913
• Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal CancerActive, not recruitingNCT05969899Phase 2
• A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer PatientsActive, not recruitingNCT05964816
• A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid TumorsStatus unknownNCT05942378Phase 1
• A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular TypingActive, not recruitingNCT05924256Phase 2
• Effects of Time-Restricted Fasting on the Postprandial Glycemic ResponsesActive, not recruitingNCT05913635Not applicable
• Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis PatientStatus unknownNCT05873972Not applicable
• Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic CancerCompletedNCT05840341Phase 3
• Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer PatientsCompletedNCT05839288
• Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRTCompletedNCT05839002
• Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）Active, not recruitingNCT05824325Phase 1/2
• The Efficacy and Safety of The Fuzuloparib Combination With BevacizumabStatus unknownNCT05819060Phase 2
• Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant TherapyStatus unknownNCT05806047Phase 2
• Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary TumorCompletedNCT05797987
• Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)CompletedNCT05794698
• Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)CompletedNCT05775796Phase 2
• Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast CancerActive, not recruitingNCT05759572Phase 2
• Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell CarcinomaStatus unknownNCT05759312Phase 1/2
• Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II StudyStatus unknownNCT05753163Phase 2
• Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRIStatus unknownNCT05744518
• Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)Status unknownNCT05732493Phase 2
• The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.Status unknownNCT05732129Phase 2
• Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During ChemoradiotherapyStatus unknownNCT05688033Not applicable
• Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.CompletedNCT05673824Phase 2
• Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC PatientsCompletedNCT05673577Phase 2
• Anatomical Resection in Colorectal Liver Metastases PatientsCompletedNCT05673564
• A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.Status unknownNCT05670925Phase 2
• a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without BiopsyStatus unknownNCT05670691
• Feasibility in Identification of Breast Cancer Candidates for Elimination of Axillary SurgeryCompletedNCT05663021Not applicable
• Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard TherapyStatus unknownNCT05643417Phase 1
• Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05638984Phase 2
• Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening ProgramStatus unknownNCT05638243
• Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell CarcinomaStatus unknownNCT05633641
• Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical CancerStatus unknownNCT05602831
• Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast CancerStatus unknownNCT05594082
• Peri-operative Foot CT Perfusion in CLI PatientsCompletedNCT05575778
• Acute Health Effects of High Temperature ExposureActive, not recruitingNCT05575752Not applicable
• Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast CancerActive, not recruitingNCT05574881Phase 1/2
• Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus TrastuzumabCompletedNCT05572645
• The Rechallenge of ADCs in MBC PatientsActive, not recruitingNCT05571618
• Health-promoting Lifestyle in a Genetic Counseling ClinicCompletedNCT05545254
• Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric CancerCompletedNCT05541783Not applicable
• VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal CancerStatus unknownNCT05540951Phase 3
• Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder CancerActive, not recruitingNCT05531123Phase 2
• Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic LesionsCompletedNCT05510037
• Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral SectionectomyCompletedNCT05506020Not applicable
• Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent ChemoradiotherapyStatus unknownNCT05483543Phase 2
• Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung CancerCompletedNCT05478460
• MammaPrint Value for Pre-menopausal Breast Cancer PatientsActive, not recruitingNCT05474391
• PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical SurgeryActive, not recruitingNCT05468138Phase 2
• Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver MetastasisCompletedNCT05462470
• Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMPTerminatedNCT05454358Phase 2/3
• Social Media-based Vaccine Confidence and Hesitancy MonitoringWithdrawnNCT05442762
• A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast CancerStatus unknownNCT05438706Phase 2
• Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard TherapyActive, not recruitingNCT05435313Phase 2
• ctDNA-based MRD Assessment in Local Advanced Esophageal CarcinomaStatus unknownNCT05426850
• Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer SurgeryCompletedNCT05408676Not applicable
• Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung CancerActive, not recruitingNCT05407155Not applicable
• Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver MetastasisStatus unknownNCT05406466Phase 2
• Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast CancerStatus unknownNCT05403333Phase 2
• Efficacy and Safety of T+A+RAD in HCCStatus unknownNCT05396937Phase 2
• Detection and Analysis of MBC With Heterogeneous ER ExpressionCompletedNCT05392985
• Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBCStatus unknownNCT05386524Phase 2
• Real-world Study of UTD1 in Chinese Advanced Breast CancerCompletedNCT05386511
• Effect of FMD on Colorectal Cancer PatientsActive, not recruitingNCT05384444Not applicable
• Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian CancerStatus unknownNCT05371301Phase 3
• Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in VivoStatus unknownNCT05354076Phase 2
• Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and TrastuzumabStatus unknownNCT05346861Phase 3
• HER2-positive Breast Cancer Project Initiated by InvestigatorsStatus unknownNCT05346328Phase 2
• HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After ResectionStatus unknownNCT05311319Phase 2
• Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)Active, not recruitingNCT05306028Phase 2
• Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant AscitesStatus unknownNCT05303844Phase 1

← Fudan University overview and focus areas